Brent Ness Biography and Net Worth

Chief Executive Officer, President, and Director of Aclarion

Mr. Ness became the Chief Executive Officer of Aclarion in September 2021. Mr. Ness has over 25 years of medical device and healthcare technology experience and has held various executive and senior leadership positions, including recently as CCO of Cleerly, Inc. At Cleerly, Mr. Ness built key industry partnerships with Canon Inc. to drive adoption of their AI-enabled cardiology solution. Previously, Mr. Ness was also the Chief Operating Officer of Mighty Oak Medical (“Mighty Oak”) whose principal products progressed from pre-FDA clearance through an international full market launch of their platform called FIREFLY.

Mr. Ness was also Chief Commercial Officer of HeartFlow, Inc., (“Heartflow”). Mr. Ness led Hearflow from pre-FDA clearance through a global expansion of early adopter sites. He also served as President of ProNerve, LLC, (“ProNerve) where he led a roll up of the highly fragmented Interoperative Nerve Monitoring Industry.

Mr. Ness has also held senior leadership roles at Medtronic, GE Healthcare, and Philips North America. He is a graduate of the University of North Dakota with a BS in Business Administration and received his MBA for the University of Colorado.

What is Brent Ness' net worth?: The estimated net worth of Brent Ness is at least $264.22 thousand as of August 13th, 2026. Mr. Ness owns 111,534 shares of Aclarion stock worth more than $264,224 as of October 8th. This net worth approximation does not reflect any other investments that Mr. Ness may own. Learn More about Brent Ness' net worth.
How do I contact Brent Ness?: The corporate mailing address for Mr. Ness and other Aclarion executives is 8181 Arista Place, Ste 100, Broomfield, CO, 80021. Aclarion can also be reached via phone at 833-275-2266. Learn More on Brent Ness' contact information.
Has Brent Ness been buying or selling shares of Aclarion?: Brent Ness has not been actively trading shares of Aclarion during the last ninety days. Most recently, on Thursday, August 13th, Brent Ness bought 5,234 shares of Aclarion stock. The stock was acquired at an average cost of $2.31 per share, with a total value of $12,090.54. Following the completion of the transaction, the chief executive officer now directly owns 111,534 shares of the company's stock, valued at $257,643.54. Learn More on Brent Ness' trading history.
Who are Aclarion's active insiders?: Aclarion's insider roster includes David Neal (Director), Brent Ness (CEO), Brent Ness (Chief Executive Officer, President, and Director), and Amanda Williams (Director). Learn More on Aclarion's active insiders.
Are insiders buying or selling shares of Aclarion?: During the last twelve months, Aclarion insiders bought shares 11 times. They purchased a total of 67,888 shares worth more than $176,647.43. The most recent insider tranaction occured on August, 17th when Director Amanda M Williams bought 5,857 shares worth more than $15,989.61. Insiders at Aclarion own 0.0% of the company. Learn More about insider trades at Aclarion.
Information on this page was last updated on 8/17/2026.

Brent Ness Insider Trading History at Aclarion

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/13/2026	Buy	5,234	$2.31	$12,090.54	111,534
5/11/2026	Buy	6,289	$3.18	$19,999.02	6,300
11/26/2025	Buy	10	$6.20	$62.00	11
12/28/2022	Buy	0	$60,782.40	$0.00

Brent Ness Buying and Selling Activity at Aclarion

Aclarion Company Overview

Aclarion, Inc., a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. It develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was incorporated in 2008 and is based in Broomfield, Colorado.

Today's Range

Now: $2.35

$2.32

$2.41

50 Day Range

MA: $2.46

$2.02

$2.94

2 Week Range

Now: $2.35

$1.95

$12.03

Volume

21,449 shs

Average Volume

325,158 shs

Market Capitalization

$6.76 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.2